The role of small intestinal bacterial overgrowth in Parkinson's disease

Movement Disorders

Volumn 28, Issue 9, 2013, Pages 1241-1249

  Fasano, Alfonso ^a,b   Bove, Francesco ^a   Gabrielli, Maurizio ^a   Petracca, Martina ^a   Zocco, Maria Assunta ^a   Ragazzoni, Enzo ^c   Barbaro, Federico ^a   Piano, Carla ^a   Fortuna, Serena ^c   Tortora, Annalisa ^a   Di Giacopo, Raffaella ^d   Campanale, Mariachiara ^a   Gigante, Giovanni ^a   Lauritano, Ernesto Cristiano ^a   Navarra, Pierluigi ^c   Marconi, Stefano ^e   Gasbarrini, Antonio ^a   Bentivoglio, Anna Rita ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF TRENTO   (Italy)

^e Medical Direction   (Italy)

Author keywords

Helicobacter pylori; Motor fluctuations; Parkinson's disease; Small intestinal bacterial overgrowth

Indexed keywords

CARBIDOPA PLUS LEVODOPA; GLUCOSE; LACTULOSE; RIFAXIMIN; UREA;

ABSENCE OF SIDE EFFECTS; AGED; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL OVERGROWTH; BACTERIUM DETECTION; BREATH ANALYSIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; ECHOGRAPHY; FEMALE; HELICOBACTER INFECTION; HUMAN; INTESTINE FLORA; MALABSORPTION; MALE; MAXIMUM PLASMA CONCENTRATION; MOTOR DYSFUNCTION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHARMACOLOGICAL PROCEDURES; PLASMA CONCENTRATION-TIME CURVE; PREVALENCE; PRIORITY JOURNAL; RECURRENCE RISK; SMALL INTESTINAL BACTERIAL OVERGROWTH; SMALL INTESTINE; STOMACH EMPTYING; TIME TO MAXIMUM PLASMA CONCENTRATION; UNIFIED PARKINSON DISEASE RATING SCALE; UREA BREATH TEST;

HELICOBACTER PYLORI; MOTOR FLUCTUATIONS; PARKINSON'S DISEASE; SMALL INTESTINAL BACTERIAL OVERGROWTH;

AGED; ANALYSIS OF VARIANCE; BETA-GALACTOSIDASE; BREATH TESTS; DISEASE ERADICATION; ENTERITIS; FEMALE; GASTRIC EMPTYING; GASTROINTESTINAL MOTILITY; GLUCOSE; HELICOBACTER INFECTIONS; HUMANS; INTESTINE, SMALL; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 84883559371     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25522     Document Type: Article

References (47)

1. Gasbarrini A, Lauritano EC, Gabrielli M, et al. Small intestinal bacterial overgrowth: diagnosis and treatment. Dig Dis. 2007;25:237-240.
2. Zietz B, Lock G, Straub RH, Braun B, Scholmerich J, Palitzsch KD. Small-bowel bacterial overgrowth in diabetic subjects is associated with cardiovascular autonomic neuropathy. Diabetes Care. 2000;23:1200-1201.
3. Lauritano EC, Bilotta AL, Gabrielli M, et al. Association between hypothyroidism and small intestinal bacterial overgrowth. J Clin Endocrinol Metab. 2007;92:4180-4184.
4. Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol. 2003;2:107-116.
5. Lewitan A, Nathanson L, Slade WR. Megacolon and dilatation of the small bowel in parkinsonism. Gastroenterology. 1952;17:367-374.
6. Eaker EY, Bixler GB, Dunn AJ, Moreshead WV, Mathias JR. Chronic alterations in jejunal myoelectric activity in rats due to MPTP. Am J Physiol. 1987;253:G809-G815.
7. Gabrielli M, Bonazzi P, Scarpellini E, et al. Prevalence of small intestinal bacterial overgrowth in Parkinson's disease. Mov Disord. 2011;26:889-892.
8. Schrag A, Quinn N. Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study. Brain. 2000;123:2297-2305.
9. Colosimo C, De Michele M. Motor fluctuations in Parkinson's disease: pathophysiology and treatment. Eur J Neurol. 1999;6:1-21.
10. Widnell K. Pathophysiology of motor fluctuations in Parkinson's disease. Mov Disord. 2005;20(Suppl 11):S17-S22.
11. Djaldetti R, Baron J, Ziv I, Melamed E. Gastric emptying in Parkinson's disease: patients with and without response fluctuations. Neurology. 1996;46:1051-1054.
12. Pierantozzi M, Pietroiusti A, Brusa L, et al. Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations. Neurology. 2006;66:1824-1829.
13. Lee WY, Yoon WT, Shin HY, Jeon SH, Rhee PL. Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease. Mov Disord. 2008;23:1696-1700.
14. Lauritano EC, Gabrielli M, Scarpellini E, et al. Small intestinal bacterial overgrowth recurrence after antibiotic therapy. Am J Gastroenterol. 2008;103:2031-2035.
15. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999;56:33-39.
16. Fahn S, Elton R, Committee. MotUD. Recent Developments in Parkinson's Disease. Folorham Park, NJ: Macmillan Health Care Information; 1987.
17. Hauser RA, Friedlander J, Zesiewicz TA, et al. A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia. Clin Neuropharmacol. 2000;23:75-81.
18. Gasbarrini A, Corazza GR, Gasbarrini G, et al. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther. 2009;29(Suppl 1):1-49.
19. Khoshini R, Dai SC, Lezcano S, Pimentel M. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci. 2008;53:1443-1454.
20. Gisbert JP, Pajares JM. Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection-a critical review. Aliment Pharmacol Ther. 2004;20:1001-1017.
21. Defer GL, Widner H, Marie RM, Remy P, Levivier M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord. 1999;14:572-584.
22. Lane RD, Glazer WM, Hansen TE, Berman WH, Kramer SI. Assessment of tardive dyskinesia using the Abnormal Involuntary Movement Scale. J Nerv Ment Dis. 1985;173:353-357.
23. Bolondi L, Bortolotti M, Santi V, Calletti T, Gaiani S, Labo G. Measurement of gastric emptying time by real-time ultrasonography. Gastroenterology. 1985;89:752-759.
24. Benini L, Sembenini C, Heading RC, et al. Simultaneous measurement of gastric emptying of a solid meal by ultrasound and by scintigraphy. Am J Gastroenterol. 1999;94:2861-2865.
25. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther. 2002;16:167-180.
26. Lang AE. A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials. Mov Disord. 2011;26:775-783.
27. Braak H, de Vos RA, Bohl J, Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett. 2006;396:67-72.
28. Phillips RJ, Walter GC, Wilder SL, Baronowsky EA, Powley TL. Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson's disease? Neuroscience. 2008;153:733-750.
29. Quigley EM. Microflora modulation of motility. J Neurogastroenterol Motil. 2011;17:140-147.
30. Wullner U, Schmitz-Hubsch T, Antony G, et al. Autonomic dysfunction in 3414 Parkinson's disease patients enrolled in the German Network on Parkinson's disease (KNP e.V.): the effect of ageing. Eur J Neurol. 2007;14:1405-1408.
31. Korchounov A, Kessler KR, Yakhno NN, Damulin IV, Schipper HI. Determinants of autonomic dysfunction in idiopathic Parkinson's disease. J Neurol. 2005;252:1530-1536.
32. Bonuccelli U, Del Dotto P, Lucetti C, et al. Diurnal motor variations to repeated doses of levodopa in Parkinson's disease. Clin Neuropharmacol. 2000;23:28-33.
33. Stocchi F, Fabbri L, Vecsei L, Krygowska-Wajs A, Monici Preti PA, Ruggieri SA. Clinical efficacy of a single afternoon dose of effervescent levodopa-carbidopa preparation (CHF 1512) in fluctuating Parkinson disease. Clin Neuropharmacol. 2007;30:18-24.
34. Wanitschke R, Ammon HV. Effects of dihydroxy bile acids and hydroxy fatty acids on the absorption of oleic acid in the human jejunum. J Clin Invest. 1978;61:178-186.
35. Nucera G, Gabrielli M, Lupascu A, et al. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2005;21:1391-1395.
36. Lomax AE, Linden DR, Mawe GM, Sharkey KA. Effects of gastrointestinal inflammation on enteroendocrine cells and enteric neural reflex circuits. Auton Neurosci. 2006;126-127:250-257.
37. Spencer RP. Intestinal absorption of amino acids. Current concepts. Am J Clin Nutr. 1969;22:292-299.
38. Varcoe R, Haliday D, Tavill AS. Utilization of urea nitrogen for albumin synthesis in the stagnant loop syndrome. Gut. 1974;15:898-902.
39. Barker HA. Amino acid degradation by anaerobic bacteria. Annu Rev Biochem. 1981;50:23-40.
40. Belay T, Sonnenfeld G. Differential effects of catecholamines on in vitro growth of pathogenic bacteria. Life Sci. 2002;71:447-456.
41. Gatto M, Fernandez Pardal M, Melero M, Zurru C, Scorticati C, Micheli F. L-dopa malabsorption in a parkinsonian patient with Strongyloides stercoralis duodenitis. Clin Neuropharmacol. 1994;17:96-98.
42. Dobbs RJ, Charlett A, Dobbs SM, Weller C, Peterson DW. Parkinsonism: differential age-trend in Helicobacter pylori antibody. Aliment Pharmacol Ther. 2000;14:1199-1205.
43. Minocha A, Mokshagundam S, Gallo SH, Rahal PS. Alterations in upper gastrointestinal motility in Helicobacter pylori-positive nonulcer dyspepsia. Am J Gastroenterol. 1994;89:1797-1800.
44. Calam J. Helicobacter pylori modulation of gastric acid. Yale J Biol Med. 1999;72:195-202.
45. Gasbarrini A, Gasbarrini G, Pelosini I, Scarpignato C. Eradication of Helicobacter pylori: are rifaximin-based regimens effective? Digestion. 2006;73(Suppl 1):129-135.
46. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord. 2010;25:2649-2653.
47. Thompson WG, Drossman DA, Talley NJ, et al. Rome III diagnostic questionnaire for the adult functional GI disorders (including alarm questions) and scoring algorithm. In: Drossman DA, Corazziari E, Delvaux M, et al, eds. ROME III, the Functional Gastrointestinal Disorders. 3rd ed. McLean, VA: Degnon Associates; 2006:917-951.